AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 152 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.86 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $235,000 | -16.4% | 5,102 | 0.0% | 0.00% | – |
| Q2 2021 | $281,000 | +6.4% | 5,102 | -0.0% | 0.00% | -100.0% |
| Q1 2021 | $264,000 | -2.9% | 5,103 | -18.8% | 0.00% | 0.0% |
| Q4 2020 | $272,000 | +6.2% | 6,285 | +31.3% | 0.00% | 0.0% |
| Q2 2020 | $256,000 | +10.8% | 4,785 | -1.0% | 0.00% | 0.0% |
| Q4 2019 | $231,000 | -3.3% | 4,835 | +0.8% | 0.00% | 0.0% |
| Q2 2019 | $239,000 | -6.3% | 4,795 | +26.7% | 0.00% | 0.0% |
| Q1 2019 | $255,000 | -13.0% | 3,785 | -0.5% | 0.00% | 0.0% |
| Q3 2018 | $293,000 | -25.6% | 3,804 | -18.7% | 0.00% | -50.0% |
| Q2 2018 | $394,000 | -64.5% | 4,681 | -71.9% | 0.00% | -60.0% |
| Q3 2017 | $1,111,000 | +29.2% | 16,650 | -0.4% | 0.01% | +25.0% |
| Q2 2017 | $860,000 | -10.7% | 16,710 | +1.4% | 0.00% | -20.0% |
| Q1 2017 | $963,000 | +54.3% | 16,482 | +10.2% | 0.01% | +25.0% |
| Q4 2016 | $624,000 | +46.1% | 14,954 | +85.1% | 0.00% | +33.3% |
| Q3 2016 | $427,000 | +24.1% | 8,079 | -2.4% | 0.00% | +50.0% |
| Q2 2016 | $344,000 | -6.8% | 8,279 | -8.8% | 0.00% | -33.3% |
| Q1 2016 | $369,000 | -37.5% | 9,079 | -0.1% | 0.00% | -40.0% |
| Q4 2015 | $590,000 | +104.9% | 9,085 | +122.4% | 0.01% | +66.7% |
| Q3 2015 | $288,000 | +46.9% | 4,085 | +96.5% | 0.00% | +50.0% |
| Q1 2015 | $196,000 | +62.0% | 2,079 | +92.7% | 0.00% | +100.0% |
| Q4 2014 | $121,000 | +89.1% | 1,079 | +2.8% | 0.00% | 0.0% |
| Q3 2014 | $64,000 | – | 1,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $80,873,000 | 75.24% |
| Casdin Capital, LLC | 187,500 | $7,855,000 | 7.82% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 40,000 | $1,676,000 | 4.87% |
| BB BIOTECH AG | 2,363,321 | $99,011,000 | 3.91% |
| AlpInvest Partners B.V. | 30,000 | $1,257,000 | 2.49% |
| Opaleye Management Inc. | 85,000 | $3,561,000 | 2.38% |
| Opus Point Partners Management, LLC | 43,295 | $1,814,000 | 1.75% |
| Clarius Group, LLC | 47,666 | $1,997,000 | 1.06% |
| CAPITAL INTERNATIONAL LTD /CA/ | 260,600 | $10,918,000 | 0.79% |
| Eventide Asset Management | 300,800 | $12,602,000 | 0.77% |